Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 8,000 shares at $51.98 ($418K) on 2015-06-23, disclosed to the SEC on 2015-06-25.
Scheduled sale ($418k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.98 | 4,899 | $255K | 60.9% |
| 2 | $52.77 | 3,101 | $164K | 39.1% |
| Total | $52.29 avg | 8,000 | $418K | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |